Search

Your search keyword '"F. LeBoeuf"' showing total 40 results

Search Constraints

Start Over You searched for: Author "F. LeBoeuf" Remove constraint Author: "F. LeBoeuf" Database MEDLINE Remove constraint Database: MEDLINE
40 results on '"F. LeBoeuf"'

Search Results

1. Status of surface electromyography assessment as part of clinical gait analysis in the management of patients with cerebral palsy - Outcomes of a Delphi process.

2. The FeetMe ® Insoles System: Repeatability, Standard Error of Measure, and Responsiveness.

3. On the accuracy of the Conventional gait Model: Distinction between marker misplacement and soft tissue artefact errors.

4. Wand-mounted lateral markers are less prone to misplacement and soft-tissue artefacts than skin-mounted markers when using the conventional gait model.

5. The Conventional Gait Model's sensitivity to lower-limb marker placement.

6. Gait Alteration Due to Haemophilic Arthropathies in Patients with Moderate Haemophilia.

7. Repeatability of the Oxford Foot Model: Comparison of a team of assessors with different backgrounds and no prior experience of the Oxford Foot Model.

8. Reliability of walking and stair climbing kinematics in a young obese population using a standard kinematic and the CGM2 model.

9. Impact of knee marker misplacement on gait kinematics of children with cerebral palsy using the Conventional Gait Model-A sensitivity study.

10. Detection of pronator muscle overactivity in children with unilateral spastic cerebral palsy: Development of a semi-automatic method using EMG data.

11. Lower limb sagittal gait kinematics can be predicted based on walking speed, gender, age and BMI.

12. "Dynamic knee valgus" - Are we measuring what we think we're measuring? An evaluation of static and functional knee calibration methods for application in gait and clinical screening tests of the overhead squat and hurdle step.

13. Effects of gleno-humeral joint centre mislocation on gleno-humeral kinematics and kinetics.

14. The effect on conventional gait model kinematics and kinetics of hip joint centre equations in adult healthy gait.

15. The conventional gait model, an open-source implementation that reproduces the past but prepares for the future.

16. The conventional gait model, an open-source implementation that reproduces the past but prepares for the future.

17. Estimation of muscle activation during different walking speeds with two mathematical approaches compared to surface EMG.

18. Neurotomy of the rectus femoris nerve: Short-term effectiveness for spastic stiff knee gait: Clinical assessment and quantitative gait analysis.

19. Pathological and physiological muscle co-activation during active elbow extension in children with unilateral cerebral palsy.

21. Muscle Activation during Gait in Children with Duchenne Muscular Dystrophy.

22. IgG1 variations in the colostrum of Holstein dairy cows.

23. Comparison of total ankle replacement and ankle arthrodesis in patients with haemophilia using gait analysis: two case reports.

24. Does muscle coactivation influence joint excursions during gait in children with and without hemiplegic cerebral palsy? Relationship between muscle coactivation and joint kinematics.

25. Impact of muscle activation on ranges of motion during active elbow movement in children with spastic hemiplegic cerebral palsy.

27. Validity and reliability of 3D marker based scapular motion analysis: a systematic review.

28. Benefits of repetitive transcranial magnetic stimulation (rTMS) for spastic subjects: clinical, functional, and biomechanical parameters for lower limb and walking in five hemiparetic patients.

30. The influence of gait speed on co-activation in unilateral spastic cerebral palsy children.

31. Detection of incoherent joint state due to inaccurate bone motion estimation.

32. Unstable gait due to spasticity of the rectus femoris: gait analysis and motor nerve block.

35. In vivo estimation of the glenohumeral joint centre by functional methods: accuracy and repeatability assessment.

36. Enhancement of dissolution rate of poorly soluble active ingredients by supercritical fluid processes. Part II: Preparation of composite particles.

37. Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I: Micronization of neat particles.

38. RhoA activation mediates phosphatidylinositol 3-kinase-dependent proliferation of human vascular endothelial cells: an alloimmune mechanism of chronic allograft nephropathy.

39. The detailed structure and behavior of discrete cooling jets in a turbine.

40. Endocrine effects of chronic administration of psychoactive drugs to prepuberal male rats. I: delta9-tetrahydrocannabinol.

Catalog

Books, media, physical & digital resources